Ranbaxy Infratech India Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 4.50 Cr
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 6.50 Cr
- Revenue Growth %
- Net Worth 1272.44%
- Total Assets 2664.65%
About Ranbaxy Infratech India
Ranbaxy Infratech India Limited (RIIL) is a Public Limited Indian Non-Government Company incorporated in India on 16 January 2015 and has a history of Ten years and one month. Its registered office is in Jalgaon, Maharashtra, India.
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹6.50 Cr.
Jayesh Nehete, Leena Nehete, and Kamal Chaudhari serve as directors at the Company.
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U45201MH2015PLC260999
- Company No.
260999
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2015
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ranbaxy Infratech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Nehete  | Managing Director | 16-Jan-2015 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Chaudhari | Director | 16-Jan-2015 | Current |
| Leena Nehete | Whole-Time Director | 16-Jan-2015 | Current |
Financial Performance of Ranbaxy Infratech India.
Ranbaxy Infratech India Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1272.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ranbaxy Infratech India?
In 2016, Ranbaxy Infratech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramstand Global LimitedJayesh Nehete, Leena Nehete and 1 more are mutual person
Charges (Loans)
₹6.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 6.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2016 | Syndicate Bank | ₹6.50 Cr | Open |
How Many Employees Work at Ranbaxy Infratech India?
Unlock and access historical data on people associated with Ranbaxy Infratech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Infratech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Infratech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
